These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 8088415

  • 1. Phosphoinositide hydrolysis in Ki-ras-transformed fibroblasts stimulated by platelet-derived growth factor and bradykinin.
    Kumada T, Banno Y, Miyata H, Nozawa Y.
    Int J Biochem; 1994 Aug; 26(8):1049-54. PubMed ID: 8088415
    [Abstract] [Full Text] [Related]

  • 2. Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin.
    Parries G, Hoebel R, Racker E.
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2648-52. PubMed ID: 2883654
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of N-ras oncogene expression on PDGF-BB stimulated responses in cultured mouse myoblasts.
    Zeytinoğlu H, Griffiths SL, Dawson AP, Gibson I.
    Cell Signal; 1995 Mar; 7(3):235-46. PubMed ID: 7544990
    [Abstract] [Full Text] [Related]

  • 5. EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinase.
    Heldman AW, Kandzari DE, Tucker RW, Crawford LE, Fearon ER, Koblan KS, Goldschmidt-Clermont PJ.
    Circ Res; 1996 Feb; 78(2):312-21. PubMed ID: 8575075
    [Abstract] [Full Text] [Related]

  • 6. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction.
    Faller DV, Mundschau LJ, Forman LW, Quiñones MA.
    J Biol Chem; 1994 Feb 18; 269(7):5022-9. PubMed ID: 8106477
    [Abstract] [Full Text] [Related]

  • 7. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.
    Ranganna K, Joshi T, Yatsu FM.
    Arterioscler Thromb Vasc Biol; 1995 Dec 18; 15(12):2273-83. PubMed ID: 7489253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential pathways (phospholipase C and phospholipase D) of bradykinin-induced biphasic 1,2-diacylglycerol formation in non-transformed and K-ras-transformed NIH-3T3 fibroblasts. Involvement of intracellular Ca2+ oscillations in phosphatidylcholine breakdown.
    Fu T, Okano Y, Nozawa Y.
    Biochem J; 1992 Apr 15; 283 ( Pt 2)(Pt 2):347-54. PubMed ID: 1575679
    [Abstract] [Full Text] [Related]

  • 10. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms.
    Hembree TN, Leeb-Lundberg LM.
    J Cell Physiol; 1996 Nov 15; 169(2):248-55. PubMed ID: 8908192
    [Abstract] [Full Text] [Related]

  • 11. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.
    Kim HR, Upadhyay S, Korsmeyer S, Deuel TF.
    J Biol Chem; 1994 Dec 02; 269(48):30604-8. PubMed ID: 7982979
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation.
    Rake JB, Quiñones MA, Faller DV.
    J Biol Chem; 1991 Mar 15; 266(8):5348-52. PubMed ID: 1848245
    [Abstract] [Full Text] [Related]

  • 13. Bradykinin B2 receptor-induced and inositol tetrakisphosphate-evoked Ca2+ entry is sensitive to a protein tyrosine phosphorylation inhibitor in ras-transformed NIH/3T3 fibroblasts.
    Hashii M, Nakashima S, Yokoyama S, Enomoto K, Minabe Y, Nozawa Y, Higashida H.
    Biochem J; 1996 Oct 15; 319 ( Pt 2)(Pt 2):649-56. PubMed ID: 8912707
    [Abstract] [Full Text] [Related]

  • 14. Common and distinct elements in insulin and PDGF signaling.
    Myers MG, Cheatham B, Fisher TL, Jachna BR, Kahn CR, Backer JM, White MF.
    Ann N Y Acad Sci; 1995 Sep 07; 766():369-87. PubMed ID: 7486683
    [Abstract] [Full Text] [Related]

  • 15. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
    Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A.
    Mol Biol Cell; 1999 Apr 07; 10(4):1093-104. PubMed ID: 10198059
    [Abstract] [Full Text] [Related]

  • 16. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254.
    Kim HK, Kim JW, Zilberstein A, Margolis B, Kim JG, Schlessinger J, Rhee SG.
    Cell; 1991 May 03; 65(3):435-41. PubMed ID: 1708307
    [Abstract] [Full Text] [Related]

  • 17. Modified kinetics of platelet-derived growth factor-induced Ca2+ increases in NIH-3T3 cells overexpressing phospholipase C gamma 1.
    Renard DC, Bolton MM, Rhee SG, Margolis BL, Zilberstein A, Schlessinger J, Thomas AP.
    Biochem J; 1992 Feb 01; 281 ( Pt 3)(Pt 3):775-84. PubMed ID: 1536654
    [Abstract] [Full Text] [Related]

  • 18. PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase.
    Liu J, Fitzli D, Liu M, Tseu I, Caniggia I, Rotin D, Post M.
    Am J Physiol; 1998 May 01; 274(5):L702-13. PubMed ID: 9612285
    [Abstract] [Full Text] [Related]

  • 19. Comparison of PDGF-AA- and PDGF-BB-induced phosphoinositide formation in human and mouse fibroblasts.
    Lassing I, Mellström K, Nistér M.
    Exp Cell Res; 1994 Apr 01; 211(2):286-95. PubMed ID: 8143775
    [Abstract] [Full Text] [Related]

  • 20. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
    Paasinen-Sohns A, Hölttä E.
    Oncogene; 1997 Oct 16; 15(16):1953-66. PubMed ID: 9365242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.